# Originclear, Inc.: financial statements, quarterly

OCLN · OTC · CIK 1419793 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ocln.md) · [Financials](/companies/ocln/financials.md) · [Filings](/companies/ocln/filings.md) · [Insiders](/companies/ocln/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ocln/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0001213900-24-068900.md) | [1.4](/filings/0001213900-23-094460.md) | [1.5 d](/filings/0001213900-25-026104.md) | [0.9](/filings/0001213900-25-045089.md) | [1.1](/filings/0001213900-25-077581.md) | [0.6](/filings/0001213900-25-112670.md) | [1.8 d](/filings/0001213900-26-042634.md) | [1.4](/filings/0001096906-26-000879.md) | [0.9](/filings/0001213900-25-077581.md) | [1.7](/filings/0001213900-25-112670.md) | [2.8 d](/filings/0001213900-26-042634.md) | [2.0](/filings/0001096906-26-000879.md) |
| Cost of revenue | $m | [0.0](/filings/0001213900-24-068900.md) | [1.1](/filings/0001213900-23-094460.md) | [1.4 d](/filings/0001213900-25-026104.md) | [1.1](/filings/0001213900-25-045089.md) | [0.4](/filings/0001213900-25-077581.md) | [0.5](/filings/0001213900-25-112670.md) | [0.9 d](/filings/0001213900-26-042634.md) | [0.9](/filings/0001096906-26-000879.md) | [1.6](/filings/0001213900-25-077581.md) | [1.2](/filings/0001213900-25-112670.md) | [1.5 d](/filings/0001213900-26-042634.md) | [1.4](/filings/0001096906-26-000879.md) |
| Gross profit | $m | [0.0](/filings/0001213900-24-068900.md) | [0.2](/filings/0001213900-23-094460.md) | [0.1 d](/filings/0001213900-25-026104.md) | [(0.1)](/filings/0001213900-25-045089.md) | [0.6](/filings/0001213900-25-077581.md) | [0.1](/filings/0001213900-25-112670.md) | [0.9 d](/filings/0001213900-26-042634.md) | [0.5](/filings/0001096906-26-000879.md) | [(0.7)](/filings/0001213900-25-077581.md) | [0.5](/filings/0001213900-25-112670.md) | [1.3 d](/filings/0001213900-26-042634.md) | [0.6](/filings/0001096906-26-000879.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(1.2)](/filings/0001213900-24-068900.md) | [(1.2)](/filings/0001213900-23-094460.md) | [(2.2) d](/filings/0001213900-25-026104.md) | [(1.9)](/filings/0001213900-25-045089.md) | [(0.9)](/filings/0001213900-25-077581.md) | [(2.2)](/filings/0001213900-25-112670.md) | [(1.2) d](/filings/0001213900-26-042634.md) | [(0.9)](/filings/0001096906-26-000879.md) | [(1.7)](/filings/0001213900-25-077581.md) | [(0.3)](/filings/0001213900-25-112670.md) | [(0.3) d](/filings/0001213900-26-042634.md) | [(0.5)](/filings/0001096906-26-000879.md) |
| Interest expense | $m | [0.5](/filings/0001213900-23-070882.md) | [0.6](/filings/0001213900-23-094460.md) | [0.7 d](/filings/0001213900-25-026104.md) | [0.6](/filings/0001213900-25-045089.md) | [0.7](/filings/0001213900-25-077581.md) | [0.7](/filings/0001213900-25-112670.md) | [0.7 d](/filings/0001213900-26-042634.md) | [0.8](/filings/0001096906-26-000879.md) | [0.2](/filings/0001213900-25-077581.md) | [0.1](/filings/0001213900-25-112670.md) | [0.2 d](/filings/0001213900-26-042634.md) | [0.1](/filings/0001096906-26-000879.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(7.7)](/filings/0001213900-24-068900.md) | [(8.3)](/filings/0001213900-23-094460.md) | [6.6 d](/filings/0001213900-25-026104.md) | [(16.1)](/filings/0001213900-25-045089.md) | [3.0](/filings/0001213900-25-077581.md) | [(2.8)](/filings/0001213900-25-112670.md) | [(2.2) d](/filings/0001213900-26-042634.md) | [(0.7)](/filings/0001096906-26-000879.md) | [(18.1)](/filings/0001213900-25-077581.md) | [(13.2)](/filings/0001213900-25-112670.md) | [13.1 d](/filings/0001213900-26-042634.md) | [(2.3)](/filings/0001096906-26-000879.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0001213900-24-068900.md) | [(0.01)](/filings/0001213900-23-094460.md) | not reported | [(0.01)](/filings/0001213900-25-045089.md) | [0.00](/filings/0001213900-24-068900.md) | not reported | not reported | [0.00](/filings/0001096906-26-000879.md) | not reported | not reported | not reported | [0.00](/filings/0001096906-26-000879.md) |
| Basic EPS | $ per share | [(0.01)](/filings/0001213900-24-068900.md) | [(0.01)](/filings/0001213900-23-094460.md) | not reported | [(0.01)](/filings/0001213900-25-045089.md) | [0.00](/filings/0001213900-24-068900.md) | not reported | not reported | [0.00](/filings/0001213900-25-045089.md) | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.4](/filings/0001213900-23-070882.md) | [1.2](/filings/0001213900-23-094460.md) | [0.5](/filings/0001213900-25-026104.md) | not reported | [0.0](/filings/0001213900-24-068900.md) | not reported | [0.4](/filings/0001213900-26-042634.md) | [1.9](/filings/0001213900-25-045089.md) | [1.2](/filings/0001213900-25-077581.md) | [0.8](/filings/0001213900-25-112670.md) | [0.8](/filings/0001096906-26-000879.md) | [3.3](/filings/0001096906-26-000879.md) |
| Current assets | $m | [3.9](/filings/0001213900-23-070882.md) | [3.6](/filings/0001213900-23-094460.md) | [2.5](/filings/0001213900-25-026104.md) | not reported | [2.0](/filings/0001213900-24-068900.md) | not reported | [4.3](/filings/0001213900-26-042634.md) | [3.5](/filings/0001213900-25-045089.md) | [2.5](/filings/0001213900-25-077581.md) | [2.1](/filings/0001213900-25-112670.md) | [5.2](/filings/0001096906-26-000879.md) | [4.4](/filings/0001096906-26-000879.md) |
| Total assets | $m | [4.7](/filings/0001213900-23-070882.md) | [4.3](/filings/0001213900-23-094460.md) | [3.1](/filings/0001213900-25-026104.md) | not reported | [2.6](/filings/0001213900-24-068900.md) | not reported | [5.0](/filings/0001213900-26-042634.md) | [4.1](/filings/0001213900-25-045089.md) | [3.1](/filings/0001213900-25-077581.md) | [2.7](/filings/0001213900-25-112670.md) | [5.7](/filings/0001096906-26-000879.md) | [5.1](/filings/0001096906-26-000879.md) |
| Current liabilities | $m | [28.5](/filings/0001213900-23-070882.md) | [35.6](/filings/0001213900-23-094460.md) | [34.7](/filings/0001213900-25-026104.md) | not reported | [44.3](/filings/0001213900-24-068900.md) | not reported | [49.8](/filings/0001213900-26-042634.md) | [47.9](/filings/0001213900-25-045089.md) | [22.0](/filings/0001213900-25-077581.md) | [25.1](/filings/0001213900-25-112670.md) | [24.2](/filings/0001096906-26-000879.md) | [26.4](/filings/0001096906-26-000879.md) |
| Total liabilities | $m | [28.7](/filings/0001213900-23-070882.md) | [35.8](/filings/0001213900-23-094460.md) | [34.9](/filings/0001213900-25-026104.md) | not reported | [46.3](/filings/0001213900-24-068900.md) | not reported | [52.3](/filings/0001213900-26-042634.md) | [50.4](/filings/0001213900-25-045089.md) | [24.5](/filings/0001213900-25-077581.md) | [27.5](/filings/0001213900-25-112670.md) | [26.7](/filings/0001096906-26-000879.md) | [27.5](/filings/0001096906-26-000879.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [2.0](/filings/0001213900-24-068900.md) | not reported | [2.0](/filings/0001213900-25-026104.md) | [2.0](/filings/0001213900-25-045089.md) | [2.0](/filings/0001213900-25-077581.md) | [2.0](/filings/0001213900-25-112670.md) | [2.6](/filings/0001213900-26-042634.md) | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(32.5)](/filings/0001213900-23-070882.md) | [(39.3)](/filings/0001213900-23-094460.md) | [(39.3)](/filings/0001213900-26-042634.md) | [(54.6)](/filings/0001213900-25-045089.md) | [(51.0)](/filings/0001213900-25-077581.md) | [(53.6)](/filings/0001213900-25-112670.md) | [(54.9)](/filings/0001096906-26-000879.md) | [(53.9)](/filings/0001096906-26-000879.md) | [(28.8)](/filings/0001213900-25-077581.md) | [(32.2)](/filings/0001213900-25-112670.md) | [(28.4)](/filings/0001096906-26-000879.md) | [(29.6)](/filings/0001096906-26-000879.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,283) d](/filings/0001213900-24-068900.md) | [(1,135) d](/filings/0001213900-23-094460.md) | [(1,096) d](/filings/0001213900-25-026104.md) | [(726)](/filings/0001213900-25-045089.md) | [(1,402) d](/filings/0001213900-25-077581.md) | [(1,017) d](/filings/0001213900-25-112670.md) | [(600) d](/filings/0001213900-26-042634.md) | [(221)](/filings/0001096906-26-000879.md) | [(1,411) d](/filings/0001213900-25-077581.md) | [(700) d](/filings/0001213900-25-112670.md) | [(1,255) d](/filings/0001213900-26-042634.md) | [1,512](/filings/0001096906-26-000879.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [7.5](/filings/0001096906-26-000879.md) | not reported | not reported | not reported | [0.0](/filings/0001096906-26-000879.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | billions of shares | [0.6](/filings/0001213900-23-070882.md) | [0.8](/filings/0001213900-23-094460.md) | [1.1](/filings/0001213900-23-042005.md) | [1.2](/filings/0001213900-24-068900.md) | [1.3](/filings/0001213900-23-094460.md) | [1.4](/filings/0001213900-25-045089.md) | [1.6](/filings/0001213900-25-077581.md) | [1.8](/filings/0001213900-25-112670.md) | [1.7](/filings/0001096906-26-000879.md) | [15.6](/filings/0001213900-25-077581.md) | [15.6](/filings/0001213900-25-112670.md) | [16.2](/filings/0001096906-26-000879.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,226,290,399 at 2026-05-26, from the cover of the [10-Q filed 2026-05-29](/filings/0001096906-26-000879.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.